Promising Approaches and Modalities for Autoimmune, Immune-Mediated, and Metabolic Diseases

The Therapeutics Stream at the PEGS Summit Boston brings together three dynamic programs showcasing the diversity of approaches driving the next generation of drug innovation. Biologics for Autoimmune Diseases will highlight novel strategies across musculoskeletal, skin, and gut disorders, alongside cutting-edge modalities and translational tools that are reshaping treatment possibilities for complex immune-mediated conditions. Advances in Immunotherapy examines new strategies to overcome resistance, address the tumor microenvironment, identify dark antigens, and advance cellular therapies for solid tumors and immune mediated conditions. And the new Emerging Peptide Therapeutics track will spotlight the surge in peptide formats, delivery mechanism, and indications and feature advances in engineering, design, delivery, and therapeutic applications including half-life extended peptides and GLP-1 agonists. Together, these programs offer a comprehensive view of the therapeutic innovations poised to change patient care.

Conferences Include:

May 10-11

Biologics for Autoimmune Diseases